1-6 of 6
Beenish Manzoor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax retreatment of real-world patients with chronic lymphocytic leukemia previously treated with venetoclax-based regimens

Free
Mazyar Shadman, Meghan Thompson, Nilanjan Ghosh, Nnadozie Emechebe, Beenish Manzoor, Godwin Okoye, Neto Coulibaly, Wendy Sinai, Sophia Li, Rajesh Kamalakar, Brian Hill
Journal: Blood
Blood (2025) 146 (Supplement 1): 2108.
https://doi.org/10.1182/blood-2025-2108
Published: 2025
Journal Articles

Evaluation of ventoclax initiation prophylaxis and monitoring outcomes at each dose level and time point in patients with chronic lymphocytic leukemia: A real-world experience

Free
Christopher Jensen, Mazyar Shadman, Andres Chang, Nicole Lamanna, Beenish Manzoor, Chaitra Ujjani, Deborah Stephens, Wendy Sinai, Brian Hill, Jennifer Brown, Hande Tuncer, Matthew S Davids, Toby Eyre, Nicolas Martinez-Calle, Lori Leslie, Lindsey Roeker, Paul Barr, Nnadozie Emechebe, Alan Skarbnik, Bita Fakhri, Meghan Thompson, Joanna Rhodes, Isabelle Fleury, Frederick Lansigan, Robson Lima, Zhu Cui, Michael Coyle, Samin Houshyar, Laurie Pearson, Irina Pivneva, Talissa Watson, Annie Guerin, Nilanjan Ghosh
Journal: Blood
Blood (2025) 146 (Supplement 1): 3885.
https://doi.org/10.1182/blood-2025-3885
Published: 2025
Journal Articles

Estimated total cost of care and patient out-of-pocket cost savings with first-line fixed duration venetoclax + obinutuzumab compared with treat-to-progression BTKi regimens among Medicare-eligible patients with chronic lymphocytic leukemia in the United States following the Inflation Reduction Act.

Free
Sophia Li, Katherine Rosettie, Beenish Manzoor, Carolina Reyes, Fadoua El Moustaid
Journal: Blood
Blood (2025) 146 (Supplement 1): 4400.
https://doi.org/10.1182/blood-2025-4400
Published: 2025
Journal Articles

Real-world overall survival and time to next treatment among elderly United States Medicare beneficiaries with chronic lymphocytic leukemia in the front-line setting

Free
Scott Huntington, Justin Puckett, Beenish Manzoor, Nnadozie Emechebe, Sophia Li, Sachin Kamal-Bahl, Carolina Reyes, Holly Budlong, Jalpa Doshi
Journal: Blood
Blood (2025) 146 (Supplement 1): 6259.
https://doi.org/10.1182/blood-2025-6259
Published: 2025
Journal Articles

Patient Experience with Venetoclax+Rituximab and BTK Inhibitors in Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL): A Qualitative Interview Study in the UK (ELECTRIC)

Free
Dima el-Sharkawi, Deborah Rahman, Lisa Lowry, Jo Kelly, Hanna Kew, Nimish Shah, Daniel Martins, Toby Kent, Louise Powell, Beenish Manzoor, Nicolas Martinez-Calle
Journal: Blood
Blood (2024) 144 (Supplement 1): 3731.
https://doi.org/10.1182/blood-2024-209883
Published: 2024
Journal Articles

Treatment Outcomes of Patients Treated with Venetoclax-Obinutuzumab Therapy Vs Btki Therapies in 1L CLL: An International Real-World Study

Free
Nicole Lamanna, Jennifer R. Brown, Chaitra S. Ujjani, Toby A. Eyre, Beenish Manzoor, Nilanjan Ghosh, Lindsey Roeker, Matthew S. Davids, Catherine C Coombs, Alan P Skarbnik, Brian T. Hill, Hande H. Tuncer, Lori A. Leslie, Joanna M. Rhodes, Isabelle Fleury, Paul M Barr, Nnadozie Emechebe, Nicolas Martinez-Calle, Christopher E. Jensen, Yun Choi, Dureshahwar Jawaid, Laurie K Pearson, Meghan C. Thompson, Steven E Marx, Wendy J. Sinai, Frederick Lansigan, Bita Fakhri, Deborah M. Stephens, Stephen J. Schuster, Michael Coyle, Irina Pivneva, Talissa Watson, Annie Guerin, Mazyar Shadman
Journal: Blood
Blood (2024) 144 (Supplement 1): 4625.
https://doi.org/10.1182/blood-2024-205223
Published: 2024